Europe To Power Higher Despite Cooling US China Relations

European bourses are looking to extend gains for a third straight session on Thursday as optimism over the reopening of economies once again overshadows rising tensions between the US and China over Hong Kong.

Last night, Washington took steps towards potentially removing the city’s special trade status. US Secretary of State Mike Pompeo said that the US no longer views Hong Kong as autonomous from mainland China. This has been the most serious response from the Trump administration over China’s crackdown on civil liberties in the financial hub.

The backdrop of cooling relations between US and China could limit gains, but we are not seeing that here is Europe at the moment. Instead stocks are bounding higher on the expectations that consumers will be coming out of lock down with an increased desire to spend, making up for those months stuck at home. This rally does of course assume that consumers will feel financially confident to continue spending.

EC’s rescue fund
The European Commission’s announced rescue fund is also going some way to boost sentiment on the continent. The fund will include €500 billion raised on the bond market. Given the size of the crisis that is hitting the region, the sums involved are small. However. it is the move towards financial integration that is being cheered by investors. This marks a clear turning point in policy.

Day ahead
Looking ahead, US data releases will be in focus, with Q1 GDP, US Durable goods and jobless claims taking centre stage. The numbers are expected to be dire, with Q1 GDP to confirm -4.8% contraction on annualised basis, and Durable goods to decline by a record -19%. Worryingly initial jobless claims are expected to remain over 2 million. There will also be a growing focus on continuing claims for signs of rehiring as states ease lockdown measures to reopen the economies.

Oil drops on larger than expected stockpiles
Whilst European futures are charging higher and US futures to a lesser extent, oil markets are extending yesterday’s steep losses. Hopes of a smooth recovery for oil from the coronavirus lockdown were dashed after oil inventories rose by more than expected.

Data from API revealed that inventories rose by 8.7 million barrels compared to expectations of a 1.9-million-barrel draw. Gasoline stocks also rose by 10 times what analysts had been expecting. These are big misses and show that whilst demand is on the road to recovery, it will be a very rocky road and is still some way off from sustaining prices.

The worse than feared US oil stockpiles added to growing nerves over Russia’s commitment to deep oil production cuts ahead of June 9th OPEC+ meeting. The last thing the oil market needs right now is another standoff between Russia and Saudi Arabia. It was the straw that broke the camel’s back in March and with demand still so fragile any further signs of Russia not being onboard with supply cuts could see oil quickly break through support at $30 per barrel.
WTI shed 4% in the previous session and is down 3% at the time of writing.

Oil levels to watch
WTI’s rally look s like it is stalling. The stock trades below its 20& 50 sma on 4 hrs chart.
Immediate support can be seen at $31.16 (today’s low) prior to $30 psychological level and $25.80 (low 14th May).
Resistance can be seen as $32.70 (50 sma) and $33.50 (20 sma) prior to $34.70 (high 26th May)

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.